4Barzon L, Boscaro M. Diagnosis and management of adrenal inciden-talomas. J Urol, 2000,163:398-407. 被引量：1
5Watanabe Y, Fukuchi S. The long-term administration of dexamethasome for the differentiation of the 4 types of hyperaldosteronism. Nippon Naibunpi Gakkai Zasshi, 1995,20:149-166. 被引量：1
6Rossi GP, Bernini G, Caliumi C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients [J]. J Am Coil Cardiol, 2006,48 ( 11 ) : 2293-2300. DOI : 10. lO16/j, jacc. 2006.07. 059. 被引量：1
7Calhoun DA, Nisbizaka MK, Zaman MA, et al. Hyperaldosteronism among black and white subjects with resistant hypertension [ J ]. Hypertension, 2002,40(6) :892-896. 被引量：1
8Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline [ J ]. J Clin Endocrinol Metab, 2008,93 ( 9 ) : 3266-3281. DOI: 10. 1210/jc. 2008-0104. 被引量：1
9Sang X, Jiang Y, Wang W, et al. Prevalence of and risk factors for primary aldosteronism among patients with resistant hypertension in China [J]. J Hypertens, 2013,31 (7) : 1465-1471 ; discussion 1471-1472. DOI: 10. 1097/HJH. ObO13e328360ddf6. 被引量：1
10Fallo F, Veglio F, Bertello C, et al. Prevalence and eharaeteristics of the metabolic syndrome in primary aldosteronism [ J ]. J Clin Endocrinol Metal), 2006,91 (2) :454-459. DOI: 10. 1210/jc. 2005-1733. 被引量：1
